MGX (Metagenomi Therapeutics) FFO


MGX Metagenomi Therapeutics Inc MGX
10 GF Score
Price $1.21
! 4 Warning Signs
View Full Analysis

What is Metagenomi Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

MGX
10GF Score
Metagenomi Therapeutics Inc MGX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metagenomi Therapeutics Business Description

Address 5959 Horton Street, 7th Floor, Emeryville, CA, USA, 94608
Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.
10GF Score

Get the complete analysis for MGX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.21
Price